TITLE

Testosterone Replacement in Diabetes and the Metabolic Syndrome

AUTHOR(S)
Jones, T. H.
PUB. DATE
May 2011
SOURCE
Internal Medicine Alert;5/29/2011 Supplement, p80
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the study conducted by T. H. Jones regarding the effects of testosterone (TST) 2% gel daily applications in hypogonadal men with type 2 diabetes (DM2) and metabolic syndrome (MBS).
ACCESSION #
61180816

 

Related Articles

  • Testosterone Replacement in Diabetes and the Metabolic Syndrome. Kuritzky, Louis // Infectious Disease Alert;Jun2011 Clinical Briefs in Primary, p12 

    The article discusses research by T. H. Jones and colleagues on the metabolic effects of testosterone replacement on diabetes, published in a 2011 issue of "Diabetes Care."

  • Testosterone Replacement in Diabetes and the Metabolic Syndrome.  // OB/GYN Clinical Alert;Jun2011 Clinical Brief, p12 

    The article presents a study which determines the effects of testosterone (TST) two percent gel when applied in hypogonadal men with type 2 diabetes (DM2) or metabolic syndrome (MBS) who underwent treatment for one year.

  • Testosterone Replacement in Diabetes and the Metabolic Syndrome. Kuritzky, Louis // Neurology Alert;Jun2011 Clinical Brief, p12 

    The article presents a study conducted by a team led by T. H. Jones and published in the "Diabetes Journal" that explored testosterone (TST) replacement in type 2 diabetes (DM2) and metabolic syndrome (MBS).

  • Abnormal Cardiac Structure and Function in the Metabolic Syndrome: A Population-Based Study. Aijaz, Bilal; Ammar, Khawaja A.; Lopez-Jimenez, Francisco; Redfield, Margaret M.; Jacobsen, Steven J.; Rodeheffer, Richard J. // Mayo Clinic Proceedings;Dec2008, Vol. 83 Issue 12, p1350 

    OBJECTIVE: To measure the association between cardiac structure and function abnormalities and isolated metabolic syndrome (metabolic syndrome excluding established hypertension or diabetes mellitus). PARTICIPANTS AND METHODS: We collected data prospectively on a population-based random sample...

  • A practical guide to diagnosis, management and treatment of testosterone deficiency for Canadian physicians. Morales, Alvaro; Bella, Anthony J.; Chun, Samuel; Lee, Jay; Assimakopoulos, Peter; Bebb, Richard; Gottesman, Irv; Alarie, Pierre; Dugré, Hélène; Elliott, Stacy // Canadian Urological Association Journal;Aug2010, Vol. 4 Issue 4, p269 

    The percentage of men receiving appropriate management for testosterone deficiency syndrome (TDS) is small in comparison to prevalence estimates. This is despite linkages to cardiovascular disease, osteoporosis, diabetes, sexual function, sarcopenia, emotional well-being and the metabolic...

  • Hormonal Modulation in Aging Patients with Erectile Dysfunction and Metabolic Syndrome. Costa, Inês Campos; Carvalho, Hugo Nogueira; Pacheco-Figueiredo, Luìs; Tomada, Inês; Tomada, Nuno // International Journal of Endocrinology;2013, p1 

    Erectile dysfunction (ED), metabolic syndrome (MetS), and hypogonadism are closely related, often coexisting in the aging male. Obesity was shown to raise the risk of ED and hypogonadism, as well as other endocrinological disturbances with impact on erectile function. We selected 179 patients...

  • Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study). JONES, T. HUGH; ARVER, STEFAN; BEHRE, HERMANN M.; BUVAT, JACQUES; MEULEMAN, ERIC; MONCADA, IGNACIO; MORALES, ANTONIO MARTIN; VOLTERRANI, MAURIZIO; YELLOWLEES, ANN; HOWELL, JULIAN D.; CHANNER, KEVIN S. // Diabetes Care;Apr2011, Vol. 34 Issue 4, p828 

    OBJECTIVE--This study evaluated the effects of testosterone replacement therapy (TRT) on insulin resistance, cardiovascular risk factors, and symptoms in hypogonadal men with type 2 diabetes and/or metabolic syndrome (MetS). RESEARCH DESIGN AND METHODS--The efficacy, safety, and tolerability of...

  • Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes. WANG, CHRISTINA; JACKSON, GRAHAM; JONES, T. HUGH; MATSUMOTO, ALVIN M.; NEHRA, AJAY; PERELMAN, MICHAEL A.; SWERDLOFF, RONALD S.; TRAISH, ABDUL; ZITZMANN, MICHAEL; CUNNINGHAM, GLENN // Diabetes Care;Jul2011, Vol. 34 Issue 7, p1669 

    The article explains the connection of obesity-based testosterone drop and metabolic syndrome to sexual dysfunction and risks of contracting heart diseases (CVDs) in men who have Type 2 diabetes. The issue was addressed based on the data gathered from a U.S. national survey, an observational...

  • Metabolic syndrome and population attributable risk among HIV/AIDS patients: comparison between NCEP-ATPIII, IDF and AHA/NHLBI definitions. Alencastro, Paulo R.; Wolff, Fernando H.; Oliveira, Renato R.; Ikeda, Maria Let�cia R; Barcellos, N�mora T.; Brand�o, Aj�cio B.M.; Fuchs, Sandra C. // AIDS Research & Therapy;2012, Vol. 9, p29 

    Background: Metabolic Syndrome (MetS) is based on the same individual components, but has received several amendments to the original definition. In this study, we verified the prevalence of metabolic syndrome according to different criteria, and the impact of each component on the diagnostic....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics